Supernus Pharmaceuticals Inc Stock Ownership - Who owns Supernus Pharmaceuticals?

Insider buying vs selling

Have Supernus Pharmaceuticals Inc insiders been buying or selling?
Charles W. Newhall IiiDirector2023-11-162,500$28.01
Charles W. Newhall IiiDirector2023-11-167,457$9.24
Frederick M. HudsonDirector2023-11-153,882$28.50
Frederick M. HudsonDirector2023-11-155,211$28.50
Frederick M. HudsonDirector2023-11-157,457$9.24
Frank MottolaSVP Quality GMP Ops IT2023-11-141,110$28.13
Frank MottolaSVP Quality GMP Ops IT2023-11-142,000$9.24
Timothy C. DecSenior Vice-President CFO2023-10-131,911$26.91
Jack A. KhattarPresident CEO2023-09-0716,804$32.10
Padmanabh P. BhattSr. VP of IP CSO2023-09-071,182$32.10

1 of 5

SUPN insiders have bought more... subscribe to Premium to read more.
Net Insider Buy/Sell (L12M) Ownership

Be the first to know when SUPN insiders and whales buy or sell their stock.

SUPN Shareholders

What type of owners hold Supernus Pharmaceuticals Inc stock?
Peter J. Barris21.71%11,859,518$319.14MInsider
Scott D. Sandell21.52%11,757,336$316.39MInsider
Forest Baskett21.50%11,746,274$316.09MInsider
Charles W. Newhall Iii19.69%10,758,339$289.51MInsider
Blackrock Inc18.63%10,179,905$273.94MInstitution
Vanguard Group Inc11.11%6,072,180$163.40MInstitution
Armistice Capital LLC9.32%5,092,000$137.03MInstitution
Krishna Kittu Kolluri7.03%3,841,172$103.37MInsider
New Enterprise Associates 11 LP6.99%3,820,625$102.81MInsider
Nea Partners 11 LP6.99%3,820,625$102.81MInsider

1 of 3

SUPN vs Pharmaceutical Stocks

TickerInst. %Insider %Net Insider (L12M)Net Insider (L3M)
SUPN45.16%54.84%Net BuyingNet Buying
TLRY12.31%2.09%Net Buying
AMRX24.05%75.95%Net Selling
IRWD72.00%28.00%Net SellingNet Buying

Supernus Pharmaceuticals Stock Ownership FAQ

Who owns Supernus Pharmaceuticals?

Supernus Pharmaceuticals (NASDAQ: SUPN) is owned by 103.64% institutional shareholders, 125.88% Supernus Pharmaceuticals insiders, and 0.00% retail investors. Peter J. Barris is the largest individual Supernus Pharmaceuticals shareholder, owning 11.86M shares representing 21.71% of the company. Peter J. Barris's Supernus Pharmaceuticals shares are currently valued at $319.14M.

If you're new to stock investing, here's how to buy Supernus Pharmaceuticals stock.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.